This test is most useful if any of these apply to you.
If you have unexplained fatigue, stubborn iron deficiency, bloating, or a close relative with celiac disease, this is the single blood test most likely to explain it. It is the first thing to reach for when celiac disease is suspected, and it catches many people who never guessed gluten was the problem.
The catch is that the result only means what it should if you are still eating gluten and your body makes normal amounts of this antibody class. Read in the right context, it is one of the most accurate screening tests in medicine.
This test measures TG2 IgA (immunoglobulin A antibodies against tissue transglutaminase type 2). IgA is one of the main classes of antibody your immune system makes, and tissue transglutaminase type 2 is an enzyme found throughout your body, including the lining of your small intestine.
In celiac disease, gluten peptides reach the gut lining, where this enzyme chemically modifies them and makes them more provoking to the immune system. That reaction eventually leads immune cells in the gut to produce IgA antibodies aimed at the enzyme itself. Those antibodies appear first in the intestinal wall and later spill into the blood, which is what this test picks up.
So the test does not measure the enzyme or gluten directly. It measures your immune system's reaction to gluten, which is why the number tracks how much gluten you are eating and how active the disease is.
This is the strongest first-line blood marker for celiac disease, and it usually gets paired with a total IgA measurement to make sure your body makes enough of this antibody class to trust the result. In people still eating gluten, its accuracy is consistently high.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Adults with biopsy-proven celiac disease versus controls (original Dieterich cohort) | Antibody positive versus negative | Correctly flagged about 98 out of 100 people with celiac disease and cleared about 95 out of 100 without it; pooled meta-analytic estimates are a little lower, closer to 93 out of 100 flagged |
| Children under two years old | Antibody test versus biopsy | Caught about 93 out of 100 young children with celiac disease and cleared about 98 out of 100 without it |
| Children with very high antibody levels | Very high result versus biopsy | Of children with very high levels, about 95 out of 100 truly had celiac disease on biopsy |
Source: Dieterich et al. 1998 (Gastroenterology); Catassi et al. 2021 meta-analysis (Nutrients); Chang et al. 2025 (Pediatrics).
What this means for you: a clearly positive result in someone eating gluten is a strong reason to pursue a celiac diagnosis, not to start a gluten-free diet on your own. Confirming the diagnosis matters, because going gluten-free before a full workup can erase the very evidence a specialist needs.
The height of the number carries real meaning. Very high results, around ten times the upper limit of normal, are far more convincing than mildly positive ones, and higher antibody levels also track with more severe flattening of the gut lining and a more symptomatic presentation.
In children, this is why very high levels can support a diagnosis without a biopsy, as long as a second blood sample confirms it. In one adult study, having both this antibody and a companion gluten antibody at more than ten times the upper limit of normal correctly identified gut damage in every single case. Mildly positive results are less certain and usually still warrant a biopsy.
This antibody is also elevated in dermatitis herpetiformis, the intensely itchy, blistering skin form of gluten sensitivity. Levels there mirror the degree of gut damage and help separate it from other blistering skin diseases that are not gluten-related. The primary skin target is a related enzyme, but the gut-directed antibody this test measures is still commonly positive.
A negative result lowers the odds of active, gluten-driven celiac disease, but it does not close the door. Some people are born making very little IgA of any kind, and in that situation this test reads falsely negative. This is exactly why a total IgA level is checked alongside it, so an IgG-based test can be used instead when needed.
Here is the finding that surprises people: celiac disease that is truly antibody-negative tends to be worse, not milder. In a long-term study, people with true seronegative celiac disease had far higher rates of complications and a higher risk of death than those who tested positive. This is not a good-number, bad-number test. A high level points to classic gluten-driven autoimmunity, while a low or negative level can mean genuine absence of disease, an IgA deficiency masking it, very early disease still confined to the gut wall, or a distinct seronegative form that carries its own risks. The way to resolve the apparent contradiction is to treat this antibody as one input, not the whole answer.
If you have type 1 diabetes, the interpretation shifts. Screening is recommended because celiac disease is common in this group, but false positives and antibodies that come and go on their own are also more frequent. In one type 1 diabetes cohort, only a small fraction were antibody-positive and none had symptoms, and standard cutoffs performed worse than in the general population.
What this means for you: a positive result with type 1 diabetes should be interpreted more cautiously and confirmed, rather than acted on immediately. A specialist may use a higher threshold before recommending biopsy.
For diagnosis, a single clearly positive reading in a gluten-eating person is powerful. For everything after diagnosis, the trend matters far more than any one value. Once you remove gluten, levels fall over months, with roughly half of children normalizing by about nine months and most within two years.
But the number is an imperfect stand-in for healing. In a meta-analysis of people on a gluten-free diet, a normal antibody level caught only about half of those who still had persistent gut damage. Levels that become completely undetectable predict a healed gut better than levels that are technically negative but still measurable.
A practical cadence: get a baseline while eating gluten, then if you are diagnosed and start a gluten-free diet, retest in 3 to 6 months to confirm the downward trend, and at least once a year after that. Rising levels are a useful early warning of hidden gluten exposure, which has been confirmed against urine gluten testing. Use the same laboratory and assay each time, because different methods normalize at different speeds and are not interchangeable.
If your result is positive but not very high, the next steps are to confirm you had a total IgA level checked, keep eating gluten, and arrange a gastroenterology evaluation, which typically includes a biopsy to settle the diagnosis. A confirmatory antibody on a second sample or an endomysial antibody test adds specificity.
If your result is negative but symptoms or family history strongly suggest celiac disease, do not stop there. Confirm your total IgA is normal, ask about IgG-based testing (such as IgG tissue transglutaminase or deamidated gliadin peptide antibodies), and consider a specialist referral, since seronegative disease still exists and can be more severe. If you already carry a diagnosis and your levels are not falling on a gluten-free diet, the most productive move is a careful review of hidden gluten exposure with a dietitian before assuming treatment failure.
Evidence-backed interventions that affect your Transglutaminase 2 IgA level
Transglutaminase 2 IgA is best interpreted alongside these tests.
Transglutaminase 2 IgA is included in these pre-built panels.